Skip to main content

Proteomic & protein analysis by mass spectrometry (MASSPROT)

pftplus |

Picture credit : Yvan Flamant - MASSPROT Woluwé

Technical and scientific expertise

Proteomics: scientific and technical advice and support at all stages of sample preparation and mass spectrometry experiments in areas such as:

  • identification and expression changes of proteins
  • identification and quantification of proteins from complex samples
  • localisation of post-translational modifications even in complex samples
  • analysis of intact proteins

Bioinformatics: advice and data analysis using appropriate IT tools and software

Main equipment

Mass spectrometry, chromatography, two-dimensional electrophoresis techniques:

  • Orbitrap Fusion Lumos Tribrid Mass spectrometer (Thermo Scientific)
  • Orbitrap Exploris 240 Mass spectrometer (Thermo Scientific)
  • Synapt G2si spectrometer (Waters)
  • Acquity MClass nano UPLC System (Waters)
  • Ultimate 3000 RSLN nano HPLC System (Thermo Scientific)

Get an overview of the platform’s facilities via a virtual tour.

Applications

  • Measurement of intact protein masses for quality control
  • Identification of purified proteins on gel
  • De novo sequencing of peptides for protein identification
  • Quantification of differential protein expression
  • Identification of covalent modification sites by peptide fragmentation/dissociation

Services available to

  • UCLouvain students and researchers
  • Non-UCLouvain parties

The latest news

  • 27 August 2025
    Autoimmune kidney diseases: the MASSPROT and BIOINFO platforms contribute to understanding the pathophysiological mechanisms of membranous nephropathy
    Thanks to the development of a more specific and sensitive proteomic analysis method, it is now possible to analyze and quantify all the peptides and proteins present in patients’ glomeruli, in order to identify the specific target antigen in each individual with membranous nephropathy.
  • 11 June 2025
    MASSPROT: supporting cancer research
    Thanks to the HDx-MS technology recently deloped within the MASSPROT platform (Woluwé site), a team of researchers from UCLouvain and the University of Lille has just reached an important milestone in cancer research by developing a revolutionary new compound: LIBX-A401.
  • 1 September 2023
    HDx-MS technology now available at MASSPROT (De Duve Institute)
    With the acquisition of a new instrument dedicated to deuterium-hydrogen exchange, funded by the Fondation Contre le Cancer, the MASSPROT mass spectrometry platform is moving towards the study of protein structure.
  • 21 August 2023
    Mass spectrometry to detect Alzheimer's disease
    The MASSPROT platform is contributing to the characterisation of proteins involved in Alzheimer's disease.